173 related articles for article (PubMed ID: 37366889)
1. Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells.
Shirono Y; Bilim V; Anraku T; Kuroki H; Kazama A; Murata M; Hiruma K; Tomita Y
Curr Oncol; 2023 May; 30(6):5350-5365. PubMed ID: 37366889
[TBL] [Abstract][Full Text] [Related]
2. Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
Dong ZC; Zhang D; Wang SB; Lin ZQ
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3018-3026. PubMed ID: 29863246
[TBL] [Abstract][Full Text] [Related]
3. 9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.
Kuroki H; Anraku T; Kazama A; Bilim V; Tasaki M; Schmitt D; Mazar AP; Giles FJ; Ugolkov A; Tomita Y
Sci Rep; 2019 Dec; 9(1):19977. PubMed ID: 31882719
[TBL] [Abstract][Full Text] [Related]
4. GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells.
Sun A; Li C; Chen R; Huang Y; Chen Q; Cui X; Liu H; Thrasher JB; Li B
Prostate; 2016 Feb; 76(2):172-83. PubMed ID: 26440826
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
Naito S; Bilim V; Yuuki K; Ugolkov A; Motoyama T; Nagaoka A; Kato T; Tomita Y
Clin Cancer Res; 2010 Nov; 16(21):5124-32. PubMed ID: 20889919
[TBL] [Abstract][Full Text] [Related]
6. MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3β/β-catenin pathway.
Dong ZC; Zhang D; Zhang XX; Yao ZQ; Wu H; Chen CH; Tian JQ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5682-5690. PubMed ID: 31298320
[TBL] [Abstract][Full Text] [Related]
7. Serine 9 and tyrosine 216 phosphorylation of GSK-3β differentially regulates autophagy in acquired cadmium resistance.
Park CH; Lee BH; Ahn SG; Yoon JH; Oh SH
Toxicol Sci; 2013 Oct; 135(2):380-9. PubMed ID: 23897984
[TBL] [Abstract][Full Text] [Related]
8. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
[TBL] [Abstract][Full Text] [Related]
9. GSK-3β Promotes Cell Migration and Inhibits Autophagy by Mediating the AMPK Pathway in Breast Cancer.
Guo L; Chen D; Yin X; Shu Q
Oncol Res; 2019 Mar; 27(4):487-494. PubMed ID: 30037362
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
Quan Y; Lei H; Wahafu W; Liu Y; Ping H; Zhang X
Biomed Pharmacother; 2019 Dec; 120():109490. PubMed ID: 31574376
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIP
Zhang N; Liu X; Liu L; Deng Z; Zeng Q; Pang W; Liu Y; Song D; Deng H
Cell Death Dis; 2018 Feb; 9(2):230. PubMed ID: 29445085
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
14. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63.
Chow SE; Chang YL; Chuang SF; Wang JS
Cancer Chemother Pharmacol; 2011 Oct; 68(4):835-45. PubMed ID: 21207227
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
17. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH
J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
Liao X; Zhang L; Thrasher JB; Du J; Li B
Mol Cancer Ther; 2003 Nov; 2(11):1215-22. PubMed ID: 14617795
[TBL] [Abstract][Full Text] [Related]
19. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
Li HL; Liang S; Cui JH; Han GY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):127-134. PubMed ID: 29364479
[TBL] [Abstract][Full Text] [Related]
20. GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer.
Ren J; Liu T; Han Y; Wang Q; Chen Y; Li G; Jiang L
Diagn Pathol; 2018 May; 13(1):33. PubMed ID: 29793508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
